Marshall Fordyce, Founder and CEO of Vera Therapeutics, shares his journey from medicine to biotech innovation. He discusses the strategic pivot towards treating autoimmune diseases, particularly Ig nephropathy with atacicept, a B-cell modulator. The conversation covers the importance of scientific rigor and adaptability in the biotech industry, while exploring the mechanisms behind new therapeutic strategies for conditions like systemic lupus. Fordyce emphasizes the balance of accountability and mentorship in navigating the evolving landscape of biotech.
